z-logo
open-access-imgOpen Access
A commentary on “PI3K‐α/mTOR/BRD4 inhibitor alone or in combination with other anti‐virals blocks replication of SARS‐CoV‐2 and its variants of concern including Delta and Omicron”
Author(s) -
Muthu Sakthijothi,
Venkatesh Sundararajan
Publication year - 2022
Publication title -
clinical and translational discovery
Language(s) - English
Resource type - Journals
ISSN - 2768-0622
DOI - 10.1002/ctd2.87
Subject(s) - pi3k/akt/mtor pathway , virology , covid-19 , viral replication , disease , pandemic , in vitro , coronavirus , computational biology , biology , medicine , virus , bioinformatics , genetics , infectious disease (medical specialty) , signal transduction , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here